Metraipolis › archive › dc_7db452f1b403
Strong Signals of Adverse Events in Tyrosine Kinase Inhibitor Therapy for Liver Cancer Treatment — Europe PMC PMID:41822321
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41822321
- DOI
- 10.14740/wjon2685
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T02:09:17.968Z
- SHA-256 of the archived text
f7c6c586bb3883831cf38abc3faaaf779ec7dfeb643063dddc9e6333889ad269- Stable URL of this page
https://metraipolis.com/documento/dc_7db452f1b403
How to cite
Strong Signals of Adverse Events in Tyrosine Kinase Inhibitor Therapy for Liver Cancer Treatment — Europe PMC PMID:41822321 — Europe PMC (en), https://europepmc.org/article/MED/41822321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7db452f1b403 (Metraipolis archive dc_7db452f1b403, sha256 f7c6c586bb3883831cf38abc3faaaf779ec7dfeb643063dddc9e6333889ad269)
BibTeX
@misc{dc7db452f1b403,
title = {Strong Signals of Adverse Events in Tyrosine Kinase Inhibitor Therapy for Liver Cancer Treatment — Europe PMC PMID:41822321},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41822321},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7db452f1b403; sha256 f7c6c586bb3883831cf38abc3faaaf779ec7dfeb643063dddc9e6333889ad269},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41822321. Agents can read the archived copy with the MCP tool read_document.